FDA approves new Alzheimer’s PET imaging agent from Lantheus

Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease.

Aug 15, 2026 - 00:00
 0  0
FDA approves new Alzheimer’s PET imaging agent from Lantheus
Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow